Back to All Events

INSIGHTS/The CEO: David Berry CEO Valo Health: How AI /ML is already disrupting drug discovery and development

David Berry has been broadly recognized as a world-leading innovator: elected as a Young Global Leader by the World Economic Forum, named as Innovator of the Year by Technology Review from amongst its Annual TR35 list, and selected as one of 12 Innovators Reshaping Reality by the U.S. State Department, alongside pioneers such as Tim Berners-Lee.

David played an instrumental role in the conception and implementation of Flagship Labs, Flagship’s company creation unit, which now is the foundation of all of its companies. 

David holds over 200 patents and patent applications. He and his companies have been awarded with over 150 additional awards and honors. David currently serves on the United Nations Sustainable Development Solutions Network (UN SDSN), where he was a Founding Leadership Council Member. 

David received his MD from Harvard Medical School and his PhD from MIT in Biological Engineering.

Previous
Previous
July 7

MASTERMIND: Mary Kerr - Creating optionality across a diverse portfolio via an “asset demerger”

Next
Next
July 14

MASTERMIND: James Field: How drug discovery & biotech companies should integrate machine learning into their drug discovery process